■超重和肥胖,高血压,高血糖症,高脂血症,胰岛素抵抗(IR)与非传染性疾病(NCDs)密切相关,包括2型糖尿病,心血管疾病,中风,和癌症。得出不同的IR替代指数,并通过正常血糖-高胰岛素钳夹(EHC)测试进行验证。因此,使用计算方法以松田指数为参考来预测IR,本研究旨在确定非糖尿病年轻成年男性替代指数的最佳临界值和诊断准确性.
■对93名年轻男性(18-31岁)进行了横断面描述性研究。在空腹状态和口服葡萄糖耐量试验(OGTT)期间分析了葡萄糖和胰岛素的血清水平。此外,临床,生物化学,荷尔蒙,并确定人体测量特征和身体成分(DEXA)。检查了使用差异参数评估IR诊断准确性和截止值的计算方法,以及其他统计工具,使输出稳健。
■在最佳截止值下的最高灵敏度和特异性,分别,建立了胰岛素抵抗指数(HOMA-IR)的稳态模型(0.91;0.98;3.40),定量胰岛素敏感性检查指数(QUICKI)(0.98;0.96;0.33),甘油三酯-葡萄糖(TyG)-腰围指数(TyG-WC)(1.00;1.00;427.77),TyG-体重指数(TyG-BMI)(1.00;1.00;132.44),TyG腰围与身高比(TyG-WHtR)(0.98;1.00;2.48),腰围与身高比(WHtR)(1.00;1.00;0.53),腰围(WC)(1.00;1.00;92.63),身体质量指数(BMI)(1.00;1.00;28.69),全身脂肪百分比(TFM)(%)(1.00;1.00;31.07),安卓脂肪(AF)(%)(1.00;0.98;40.33),脂质积累产物(LAP)(0.84;1.00;45.49),瘦素(0.91;1.00;16.08),瘦素/脂联素比值(LAR)(0.84;1.00;1.17),空腹胰岛素(0.91;0.98;16.01)。
■计算方法用于确定诊断准确性和用于预防保健的IR的最佳截止值。
UNASSIGNED: Overweight and obesity, high blood pressure, hyperglycemia, hyperlipidemia, and insulin resistance (IR) are strongly associated with non-communicable diseases (NCDs), including type 2 diabetes, cardiovascular disease, stroke, and cancer. Different surrogate indices of IR are derived and validated with the euglycemic-hyperinsulinemic clamp (EHC) test. Thus, using a computational approach to predict IR with Matsuda index as reference, this study aimed to determine the optimal cutoff value and diagnosis accuracy for surrogate indices in non-diabetic young adult men.
UNASSIGNED: A cross-sectional descriptive study was carried out with 93 young men (ages 18-31). Serum levels of glucose and insulin were analyzed in the fasting state and during an oral glucose tolerance test (OGTT). Additionally, clinical, biochemical, hormonal, and anthropometric characteristics and body composition (DEXA) were determined. The computational approach to evaluate the IR diagnostic accuracy and cutoff value using difference parameters was examined, as well as other statistical tools to make the output robust.
UNASSIGNED: The highest sensitivity and specificity at the optimal cutoff value, respectively, were established for the Homeostasis model assessment of insulin resistance index (HOMA-IR) (0.91; 0.98; 3.40), the Quantitative insulin sensitivity check index (QUICKI) (0.98; 0.96; 0.33), the triglyceride-glucose (TyG)-waist circumference index (TyG-WC) (1.00; 1.00; 427.77), the TyG-body mass index (TyG-BMI) (1.00; 1.00; 132.44), TyG-waist-to-height ratio (TyG-WHtR) (0.98; 1.00; 2.48), waist-to-height ratio (WHtR) (1.00; 1.00; 0.53), waist circumference (WC) (1.00; 1.00; 92.63), body mass index (BMI) (1.00; 1.00; 28.69), total body fat percentage (TFM) (%) (1.00; 1.00; 31.07), android fat (AF) (%) (1.00; 0.98; 40.33), lipid accumulation product (LAP) (0.84; 1.00; 45.49), leptin (0.91; 1.00; 16.08), leptin/adiponectin ratio (LAR) (0.84; 1.00; 1.17), and fasting insulin (0.91; 0.98; 16.01).
UNASSIGNED: The computational approach was used to determine the diagnosis accuracy and the optimal cutoff value for IR to be used in preventive healthcare.